99.7%GLP-1
Semaglutide
5mg · 99.7%
360AED
View→Weight Management
GLP-1 and dual-agonist reference sequences for metabolic research models.
99.7%99.9%GIP/GLP-1
Tirzepatide
10mg · 99.9%
405AED
View→99.6%LY-3437943
Retatrutide
10mg · 99.6%
455AED
View→99.4%hGH frag 177-191
AOD-9604
5mg · 99.4%
190AED
View→99.2%NS-2330
Tesofensine
500mcg × 30 · 99.2%
240AED
View→99.5%AM-833
Cagrilintide
5mg · 99.5%
380AED
View→99.9%GIP/GLP-1
Tirzepatide
15mg · 99.9%
550AED
View→99.9%GIP/GLP-1
Tirzepatide
20mg · 99.9%
670AED
View→99.9%GIP/GLP-1
Tirzepatide
30mg · 99.9%
925AED
View→99.9%GIP/GLP-1
Tirzepatide
40mg · 99.9%
1,120AED
View→99.9%GIP/GLP-1
Tirzepatide
50mg · 99.9%
1,305AED
View→99.9%GIP/GLP-1
Tirzepatide
60mg · 99.9%
1,515AED
View→99.6%LY-3437943
Retatrutide
15mg · 99.6%
570AED
View→99.6%LY-3437943
Retatrutide
20mg · 99.6%
740AED
View→99.6%LY-3437943
Retatrutide
30mg · 99.6%
965AED
View→99.6%LY-3437943
Retatrutide
40mg · 99.6%
1,215AED
View→99.6%LY-3437943
Retatrutide
50mg · 99.6%
1,470AED
View→99.6%LY-3437943
Retatrutide
60mg · 99.6%
1,720AED
View→99.4%hGH frag 177-191
AOD-9604
10mg · 99.4%
360AED
View→